Senator Sanders to ask why drug, once free, now costs $375k | Reuters

WASHINGTON (Reuters) – U.S. Senator Bernie Sanders plans to send a letter to Catalyst Pharmaceuticals (CPRX.O) on Monday asking it to justify its decision to charge $375,000 annually for a medication that for years has been available to patients for free.

via Senator Sanders to ask why drug, once free, now costs $375k | Reuters